The Food and Drug Administration has approved Veozah (fezolinetant), a drug to treat symptoms of menopause. The drug, produced by Tokyo-headquartered Astellas Pharma, was found to significantly ...

The US Food and Drug Administration on Friday approved a ... insomnia, back pain, hot flush and elevated liver enzymes. CNN’s Meg Tirrell contributed to this report.

The menopause treatment fezolinetant has been predicted as a “gamechanger” by experts for thousands of women who suffer from hot flushes. The drug, which is the first non-hormonal menopause ...

“We shouldn’t be thinking about flushes as an enigma,” as had ... cancer and women on the cancer remission drug tamoxifen, for whom hot flashes are a common side effect, Neal-Perry says.

Within a day or two the flushes go away ... Veozah is the first and only drug that works this way to help with hot flashes, according to the FDA. During and after menopause, up to 75% of women ...

These findings provide further evidence of the benefits of using this non-hormonal preventative drug in women experiencing hot flushes during menopause. Hot flushes and night sweats, also known as ...

A “BLOCKBUSTER” new menopause drug that helps eliminate hot flushes has been approved in the UK. Fezolinetant — sold as Veoza — was authorised by the Medicines and Healthcare products ...

The drug has not yet been recommended for the ... from the Medicines and Healthcare products Regulatory Agency (MHRA), said: "Hot flushes and night sweats caused by menopause are common and ...

Trials showed that after 12 weeks of use the drug reduced the frequency of hot flushes by 60%. It also reduced the severity of flushes and improved sleep. Women reported an instant impact after ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...